Skylight Health Group Inc.

As of June 30, 2022, Skylight Health Group Inc. carries a market capitalization of 19.11M, placing it among publicly traded companies globally. Its enterprise value stands at 47.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Skylight Health Group Inc.'s next confirmed earnings release is scheduled for November 19, 2026.

As of June 30, 2022, Skylight Health Group Inc. has 39.82M shares outstanding.

These figures are as of June 30, 2022. The price-to-sales ratio is 0.67, and the price-to-book ratio stands at 1.23.

These figures are as of June 30, 2022. The EV/Sales ratio of 1.70 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 47.49M versus a market cap of 19.11M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2022, Skylight Health Group Inc. maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 117.43, indicating elevated leverage, while an interest coverage ratio of -10.51 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2022, Skylight Health Group Inc. posted a negative return on equity (ROE) of -70.81, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -29.80, reflecting losses generated across the asset base. The company generates approximately 130,697.15 in revenue per employee across its workforce of 214.25, a quick read on workforce productivity versus industry peers.

As of the close on September 25, 2026, Skylight Health Group Inc.'s stock has gained approximately 9900.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

Over the twelve months ended June 30, 2022, Skylight Health Group Inc. generated 28.00M in revenue and converted that into -15.61M in net income, yielding earnings per share of -0.56. EBITDA reached -18.11M, while operating income came in at -21.56M.

As of June 30, 2022, Skylight Health Group Inc. holds 1.75M in cash and equivalents against 24.66M in total debt, resulting in a net debt position of 6.29M. Total book value stands at 15.53M, with working capital of 2.54M providing operational flexibility.

Skylight Health Group Inc. produced -13.22M in operating cash flow over the twelve months ended June 30, 2022. After subtracting -184,120.57 in capital expenditures, free cash flow totaled -13.40M - equivalent to -0.34 per share.

Over the twelve months ended June 30, 2022, Skylight Health Group Inc. posted a gross margin of 35.99, reflecting its pricing power and cost economics. The operating margin of -77.00 and net profit margin of -55.75 provide insight into operational efficiency.

Over the twelve months ended June 30, 2022, Skylight Health Group Inc. paid dividends of 0.01 per share. The dividend payout ratio of -1.55 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -71.46: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -58.80, meaning Skylight Health Group Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Skylight Health Group Inc.'s most recent stock split took place on May 28, 2021 with a 5:1 split ratio.

As of June 30, 2022, Skylight Health Group Inc. has an Altman Z-Score of -2.40, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.